Mineralys Therapeutics CEO Jon Congleton sells $1,909,665 in common shares

MLYS•2026-10-02

CEO Jon Congleton sold 75,000 Mineralys Therapeutics shares on Sept. 30, 2026, at a weighted-average price of $25.4622 per share. His direct holdings fell to 528,621 shares.

1. Share sale

Congleton sold 75,000 common shares on Sept. 30, 2026, at a weighted-average price of $25.4622 per share. After the transaction, his direct holdings totaled 528,621 shares.

Sources

Mineralys Therapeutics CEO Jon Congleton sells $1,909,665 in common shares

Sec

Mineralys Therapeutics CEO Jon Congleton sells $1,909,665 in common shares

1. Share sale

Related News

UGI unit issues $30 million of 5.95% senior notes due Sept. 28, 2038

CL Workshop Group enters $200 million at-the-market offering program with Chaince Securities

Ares Strategic Income Fund says Cox Capital Partners offers $23.15 per share in mini-tender

Sources

Mineralys Therapeutics CEO Jon Congleton sells $1,909,665 in common shares

PGE to host third-quarter earnings conference call and webcast

Silynxcom may offer up to $1.30 million in ordinary shares through sales agent